Effects of COVID-19 Pandemic on Treatment, Follow-up, and Lifestyle and Behavioral Characteristics in People Living with HIV

Year 2021, Volume: 74 Issue: 2, 166 - 171, 25.05.2021

Müge Ayhan

Abstract

Objectives: Limited available data currently indicate that the course of Coronavirus disease-2019 (COVID-19) in people living with human immunodeficiency virus (HIV) does not differ from people without HIV. During overstressing circumstances like pandemics, it is important to know how the population, especially special groups, are coping with such a major disaster. Measures and policies which are adopted according to this special patient group can change the quality of care in HIV patients. Health authorities have implemented some policies for elderly and special patient populations. In this study, it was aimed to evaluate the impact of the COVID-19 pandemic on treatment, follow-up and lifestyle and behavioral characteristics of HIV patients.

Materials and Methods: A phone survey was applied to all HIV patients who were followed regularly in our center. A total of 100 patients were included. The patients were asked about whether there was a disruption in follow-up and treatment. In addition, patient groups with and without anxiety were compared.

Results: Education level was higher and the duration of HIV infection was longer in the patient group with anxiety (p=0.01 and p=0.007, respectively). The groups were compared for follow-up disruption. Disruption of follow-up was more frequent in retired, working and student patients (p=0.01). Eighty-five percent stated that they adopted lifestyle and behavioral changes due to COVID-19.

Conclusion: Compliance with measures was sufficient and no patient was infected with the novel coronavirus. The appropriate measures and correct policies implemented by the authorities and patients’ compliance with the protective measures have played a major role in ensuring the continuity of treatment of patients with chronic illnesses like HIV infection.

Keywords

COVID-19, HIV Infection, Treatment, Pandemic, Anxiety

Ethical Statement

pproved by Ankara City Hospital Clinical Researchs Ethics Committee No:1. Informed Consent: All patients were informed about the study and content of the survey; verbal consent was taken by answering a yes-no question. Peer-reviewed: Externally peer-reviewed.

Supporting Institution

-

Project Number

-

Thanks

-

References

• 1. Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med. 2020;14:126-135.
• 2. Mungroo MR, Khan NA, Siddiqui R. Novel Coronavirus: Current Understanding of Clinical Features, Diagnosis, Pathogenesis, and Treatment Options. Pathogens. 2020;9:297.
• 3. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91:157-160.
• 4. COVID-19 Coronavirus Pandemic. https://www.worldometers.info/ coronavirus/ (2020).
• 5. Demirbilek Y, Pehlivantürk G, Özgüler ZÖ, et al. COVID-19 outbreak control, example of ministry of health of Turkey. Turk J Med Sci. 2020;50:489-494.
• 6. Blanco JL, Ambrosioni J, Garcia F, et al. COVID-19 in patients with HIV: clinical case series. Lancet HIV. 2020;7:314-316.
• 7. Laurence J. Why Aren’t People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)? AIDS Patient Care STDS. 2020;34:247-248.
• 8. Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. Lancet HIV. 2020;7:308-309.
• 9. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069.
• 10. Jones R, Nelson M, Bracchi, M, Asboe, D, Boffito M. COVID-19 in patients with HIV. Lancet HIV 7, e383 (2020).
• 11. Interim Guidance for COVID-19 and Persons with HIV. https://aidsinfo. nih.gov/guidelines/html/8/covid-19-and-persons-with-hiv--interimguidance-/ 554/interim-guidance-for-covid-19-and-persons-with-hiv.
• 12. Zhang Y, Ma ZF. Impact of the COVID-19 Pandemic on Mental Health and MQuality of Life among Local Residents in Liaoning Province, China: A Cross- Sectional Study. Int J Environ Res Public Health. 2020;17:2381.
• 13. Betsch C, Wieler LH, Habersaat K; COSMO group. Monitoring behavioural insights related to COVID-19. Lancet. 2020;395:1255-1256.
• 14. Cheng SK, Wong CW, Tsang J, et al. Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS). Psychol MMed. 2004;34:1187-1195.
• 15. Brandt C, Zvolensky MJ, Woods SP, et al. Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literature. Clin Psychol Rev. 2017;51:164-184.
• 16. Pulvirenti F, Cinetto F, Milito C, et al. Health-Related Quality of Life in Common Variable Immunodeficiency Italian Patients Switched to Remote Assistance During the COVID-19 Pandemic. J Allergy Clin Immunol Pract. 2020;8:1894-1899.
• 17. Al-Hanawi MK, Angawi K, Alshareef N, et al. Knowledge, Attitude and Practice Toward COVID-19 Among the Public in the Kingdom of Saudi Arabia: A Cross-Sectional Study. Front Public Health. 2020;8:217.
• 18. Kronik Hastalığı Bulunan Sigortalılarımızın Sağlık Raporları ve Reçeteleri İkinci Bir Duyuruya Kadar Geçerli Sayılacak. https://web.archive.org/save/ https://www.ailevecalisma.gov.tr/tr-tr/haberler/bakan-selcuk-kronikhastaligi- bulunan-sigortalilarimizin-saglik-raporlari-ve-receteleri-ikincibir- duyuraya-kadar-gecerli-sayilacak/.